Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 50228-461

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 50228-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 25mg 100mg Container Label 1000s)

Each tablet contains 25 mg of Carbidopa, USP and 100 g of Tewadopa, USP. It is recommended for adults to see the package for the correct dosage. These tablets should be swallowed whole without crushing or chewing. The medication should be kept in a tight, light-resistant container with a child-resistant closure. The container must be kept tightly closed and away from the reach of children. This medication is manufactured by SciGen Pharmaceuticals, Inc. This description provides information on the usage of Carbidopa and Levodopa Tablets.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 25mg 100mg Container Label 100s)

This is a medication called Levodopa USP in tablet form. Each tablet contains 25mg of carbidopa USP and 100mg of levodopa USP. The recommended dosage is indicated on the package insert. The medication should be stored at a controlled room temperature of 15-30°C (59-86°F) and dispensed in a tight, light-resistant container. Keep the container tightly closed and out of reach of children. It is manufactured by Screen Pharmaceuticals and is available by prescription only.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 25mg 100mg Container Label 30s)

This is a description for a medication consisting of tablets that contain 25mg of Carbidopa, USP and 100mg of Levodopa, USP. The medication is for adult use and should not be chewed or crushed. It can be stored at room temperature, between 20-25°C (68°-77°F), with permitted excursions between 15°-30°C (59°-36°F). The medication should be kept in a container tightly sealed and away from children. The tablets are extended-release and come in a pack of 30. The manufacturer of the medication is ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY 11788. The National Drug Code (NDC) for the medication is 50228-460-30.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 50mg 200mg Container Label 1000s)

This is a medication called Carbidopa and Levodopa Extended-Release Tablets with each tablet containing 50mg of Carbidopa, USP, and 200mg of Levodopa, USP. The medication is intended for adult use only, and the dosage information is available on the package insert. It is important to store the tablets at a temperature range of 20°C to 25°C and to keep them out of reach of children. The tablets should be dispensed in a light-resistant container with a child-resistant closure. The manufacturer is ScieGen Pharmaceuticals Inc., located in Hauppauge, NY, and the medication is available in a pack of 1000 tablets.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 50mg 200mg Container Label 100s)

This is a medication containing 50mg of carbidopa USP and levodopa USP in each tablet. It is typically used by adults, and the recommended dosage can be found in "Feckaon et Carbidopa and Levodopa". The tablets should be swallowed whole, and not chewed or crushed. They should be stored in a container that is both light-resistant and acid-resistant, at a temperature between 15°C and 30°C. The medication should be dispensed in a tightly-sealed container that is defined by the USP. This medication is manufactured by ScieGen and should be kept out of the reach of children.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 50mg 200mg Container Label 30s)

This is a medication consisting of tablets containing 50mg of Carbidopa, USP and 200mg of Levodopa, USP. The tablets should be swallowed without chewing or crushing, and stored in a container between 20-25°C. Dispensing the medication in a tightly closed, light-resistant container is recommended. The medication is intended for adult use only, and should be kept out of the reach of children. The manufacturer is ScieGen Pharmaceuticals, and the medication is available in bottles containing 30 tablets. Rx prescription is required for use.*

FDA Label Image

Carbidopa Chemical Structure (Cls Tabs Carbi Str)

FDA Label Image

Levodopa Chemical Structure (Cls Tabs Levo Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.